{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T03:12:16Z","timestamp":1777864336558,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Uniwersytet Medyczny im. Piast\u00f3w Slaskich we Wroclawiu","doi-asserted-by":"publisher","award":["-882"],"award-info":[{"award-number":["-882"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.peptides.2019.170169","type":"journal-article","created":{"date-parts":[[2019,9,26]],"date-time":"2019-09-26T16:45:03Z","timestamp":1569516303000},"page":"170169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Systemic hepcidin quantified with LC\u2013MS\/MS in dementia in association with disease pathology and severity and with structural changes in the brain"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7857-327X","authenticated-orcid":false,"given":"Mariusz G.","family":"Fleszar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"Wi\u015bniewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabela","family":"Berdowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Zieli\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzena","family":"Zboch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Diakowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Gamian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Krzystek-Korpacka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2019.170169_bib0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and meta analysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.peptides.2019.170169_bib0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","article-title":"A review on Alzheimer\u2019s disease pathophysiology and its management: an update","volume":"67","author":"Kumar","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.peptides.2019.170169_bib0015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","article-title":"2017 Alzheimer\u2019s disease facts and figures","volume":"13","author":"Alzheimer\u2019s Association","year":"2017","journal-title":"Alzheimer\u2019s Dement."},{"key":"10.1016\/j.peptides.2019.170169_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-018-1399-5","article-title":"Hepcidin, an emerging and important player in brain iron homeostasis","volume":"16","author":"Vela","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.peptides.2019.170169_bib0025","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1210\/en.2007-1626","article-title":"Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain","volume":"149","author":"Wang","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.peptides.2019.170169_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00018-009-0167-3","article-title":"Role of hepcidin in murine brain iron metabolism","volume":"67","author":"Wang","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.peptides.2019.170169_bib0035","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00702-010-0470-z","article-title":"Brain iron metabolism and its perturbation in neurological diseases","volume":"118","author":"Crichton","year":"2011","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.peptides.2019.170169_bib0040","series-title":"Oxidative Stress Free Radic. Damage Neurol.","first-page":"19","article-title":"Why is the nervous system vulnerable to oxidative stress?","author":"Friedman","year":"2010"},{"key":"10.1016\/j.peptides.2019.170169_bib0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5607\/en.2015.24.4.325","article-title":"The role of oxidative stress in neurodegenerative diseases","volume":"24","author":"Kim","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.peptides.2019.170169_bib0050","article-title":"The role of Iron homeostasis in Alzheimer\u2019s disease","volume":"3","author":"Manolov","year":"2017","journal-title":"J. Alzheimers Neurodegener."},{"key":"10.1016\/j.peptides.2019.170169_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14336\/AD.2016.0811","article-title":"Serum hepcidin levels, iron dyshomeostasis and cognitive loss in Alzheimer\u2019s disease","volume":"8","author":"Sternberg","year":"2017","journal-title":"Aging Dis."},{"key":"10.1016\/j.peptides.2019.170169_bib0060","doi-asserted-by":"crossref","first-page":"e25324","DOI":"10.1371\/journal.pone.0025324","article-title":"Hepcidin is involved in iron regulation in the ischemic brain","volume":"6","author":"Ding","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2019.170169_bib0065","volume":"Vol. 4","author":"American Psychiatric Association","year":"1990"},{"key":"10.1016\/j.peptides.2019.170169_bib0070","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer\u2019s disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.peptides.2019.170169_bib0075","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archneur.1975.00490510088009","article-title":"Cerebral blood flow in dementia","volume":"32","author":"Hachinski","year":"1975","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.peptides.2019.170169_bib0080","first-page":"39","article-title":"ICD-10 transition","volume":"18","author":"World Health Organization (WHO)","year":"2011","journal-title":"Fam. Pract. Manag."},{"key":"10.1016\/j.peptides.2019.170169_bib0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2165\/00023210-199912010-00004","article-title":"Cerebrovascular dementia: pathophysiology, diagnosis and treatment","volume":"12","author":"Erkinjuntti","year":"1999","journal-title":"CNS Drugs"},{"key":"10.1016\/j.peptides.2019.170169_bib0090","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s13244-016-0521-6","article-title":"Imaging biomarkers of dementia: recommended visual rating scales with teaching cases","volume":"8","author":"Wahlund","year":"2017","journal-title":"Insights Imaging"},{"key":"10.1016\/j.peptides.2019.170169_bib0095","unstructured":"M. ADRC, Clinical Dementia Rating (CDR) Scale, (n.d.). http:\/\/madrc.mgh.harvard.edu\/clinical-dementia-rating-cdr-scale. (Accessed 4 November 2017)."},{"key":"10.1016\/j.peptides.2019.170169_bib0100","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.peptides.2019.170169_bib0105","first-page":"61","article-title":"Znaczenie badania neuropsychologicznego w diagnostyce ot\u0119pienia","volume":"3","author":"Kotapka-Minc","year":"2007","journal-title":"Pol. Prz. Neurol."},{"key":"10.1016\/j.peptides.2019.170169_bib0110","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.peptides.2019.170169_bib0115","first-page":"455","article-title":"Overview of the MNA\u2014its history and challenges","volume":"10","author":"Vellas","year":"2006","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.peptides.2019.170169_bib0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jns.2019.06.008","article-title":"Clinical utility of serum hepcidin and iron profile measurements in Alzheimer\u2019s disease","volume":"403","author":"Kweon","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.peptides.2019.170169_bib0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.euprot.2014.02.004","article-title":"Clinical measurement of Hepcidin-25 in human serum: is quantitative mass spectrometry up to the job?","volume":"3","author":"Delaby","year":"2014","journal-title":"EuPA Open Proteom."},{"key":"10.1016\/j.peptides.2019.170169_bib0130","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.3319","article-title":"Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography\/ selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up","volume":"21","author":"Murao","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.peptides.2019.170169_bib0135","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1182\/blood-2006-11-057471","article-title":"Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry","volume":"110","author":"Murphy","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.peptides.2019.170169_bib0140","doi-asserted-by":"crossref","first-page":"9046","DOI":"10.1016\/j.chroma.2011.10.030","article-title":"Development of a nano-liquid chromatography on chip tandem mass spectrometry method for high-sensitivity hepcidin quantitation","volume":"1218","author":"Houbart","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.peptides.2019.170169_bib0145","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jchromb.2005.01.011","article-title":"Simple means to alleviate sensitivity loss by trifluoroacetic acid (TFA) mobile phases in the hydrophilic interaction chromatography-electrospray tandem mass spectrometric (HILIC-ESI\/MS\/MS) bioanalysis of basic compounds","volume":"825","author":"Shou","year":"2005","journal-title":"J. Chromatogr. B: Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.peptides.2019.170169_bib0150","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.cca.2011.08.014","article-title":"Effects of a single dose of oral iron on hepcidin concentrations in human urine and serum analyzed by a robust LC\u2013MS\/MS method","volume":"412","author":"Hwang","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.peptides.2019.170169_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-43756-9","article-title":"A targeted mass spectrometric assay for reliable sensitive hepcidin quantification","volume":"9","author":"Moghieb","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.peptides.2019.170169_bib0160","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1373\/clinchem.2008.107029","article-title":"Quantification of hepcidin-25 in human serum by isotope dilution micro-HPLC-tandem mass spectrometry","volume":"54","author":"Kobold","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.peptides.2019.170169_bib0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.vascn.2009.02.004","article-title":"Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC\u2013MS\/MS","volume":"59","author":"Li","year":"2009","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.peptides.2019.170169_bib0170","doi-asserted-by":"crossref","first-page":"NP50","DOI":"10.1177\/1747493015623557","article-title":"Serum hepcidin levels and stroke in thalassemia patients","volume":"11","author":"Petrova","year":"2016","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.peptides.2019.170169_bib0175","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.031","article-title":"Hepcidin levels are increased in patients with acute ischemic stroke: preliminary report","volume":"24","author":"Slomka","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.peptides.2019.170169_bib0180","doi-asserted-by":"crossref","first-page":"e2921","DOI":"10.1097\/MD.0000000000002921","article-title":"Serum hepcidin levels in childhood-onset ischemic stroke: a case-control study","volume":"95","author":"Azab","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.peptides.2019.170169_bib0185","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1007\/s12035-016-0067-0","article-title":"Expression of Iron transporters and pathological hallmarks of Parkinson\u2019s and Alzheimer\u2019s diseases in the brain of young, adult, and aged rats","volume":"54","author":"Lu","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.peptides.2019.170169_bib0190","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/2051-5960-1-55","article-title":"The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer\u2019s disease","volume":"1","author":"Raha","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.peptides.2019.170169_bib0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2015.08.007","article-title":"The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer\u2019s disease: two sides of the same coin","volume":"81","author":"Peters","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.peptides.2019.170169_bib0200","doi-asserted-by":"crossref","first-page":"e2676","DOI":"10.1038\/cddis.2017.93","article-title":"Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis","volume":"8","author":"You","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.peptides.2019.170169_bib0205","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/jnc.12244","article-title":"Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells","volume":"126","author":"Urrutia","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.170169_bib0210","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2012-10-461418","article-title":"Circulatory hepcidin is associated with the anti-in flammatory response but not with iron or anemic status in childhood malaria","volume":"121","author":"Burte","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.peptides.2019.170169_bib0215","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1172\/JCI42011","article-title":"Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice","volume":"120","author":"De Domenico","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2019.170169_bib0220","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/jnc.14005","article-title":"Hepcidin attenuates amyloid beta-induced inflammatory and pro-oxidant responses in astrocytes and microglia","volume":"142","author":"Urrutia","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.170169_bib0225","doi-asserted-by":"crossref","first-page":"56","DOI":"10.15343\/0104-7809.200832.1.7","article-title":"Avalia\u00e7\u00e3o do equil\u00edbrio postural em idosos praticantes de hidroterapia em grupo","volume":"32","author":"Bruni","year":"2008","journal-title":"O Mundo Da Sa\u00fade"},{"key":"10.1016\/j.peptides.2019.170169_bib0230","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.peptides.2019.170169_bib0235","series-title":"Stroke","first-page":"252","article-title":"17 - Vascular dementia and vascular cognitive decline","author":"Seshadri","year":"2011"},{"key":"10.1016\/j.peptides.2019.170169_bib0240","first-page":"64","article-title":"Montreal cognitive assessment in assessing clinical severity and white matter hyperintensity in Alzheimer\u2019s disease with normal control comparison","volume":"21","author":"Chang","year":"2012","journal-title":"Acta Neurol. Taiwan"},{"key":"10.1016\/j.peptides.2019.170169_bib0245","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5114\/ninp.2012.28255","article-title":"Clinical application of the Polish adaptation of the Montreal Cognitive Assessment (MoCA) test in screening for cognitive impairment","volume":"46","author":"Magierska","year":"2012","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.peptides.2019.170169_bib0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-141173","article-title":"Eye movements in Alzheimer\u2019s disease","volume":"44","author":"Molitor","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.peptides.2019.170169_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2017.00377","article-title":"Eyetracking metrics in young onset Alzheimer\u2019s disease: a window into cognitive visual functions","volume":"8","author":"Pavisic","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.peptides.2019.170169_bib0260","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/852784","article-title":"Clinical correlates of Hachinski ischemic score and vascular factors in cognitive function of elderly","volume":"2014","author":"Kim","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.peptides.2019.170169_bib0265","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1055\/s-0028-1083695","article-title":"Neuroimaging in dementia","volume":"28","author":"Vitali","year":"2008","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.peptides.2019.170169_bib0270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1474-4422(02)00002-9","article-title":"Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion","volume":"1","author":"Scheltens","year":"2002","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.peptides.2019.170169_bib0275","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/j.1537-2995.2012.03916.x","article-title":"The effect of frequent whole blood donation on ferritin, hepcidin, and subclinical atherosclerosis","volume":"53","author":"Peffer","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.peptides.2019.170169_bib0280","doi-asserted-by":"crossref","first-page":"8209","DOI":"10.3892\/mmr.2017.7668","article-title":"Brain iron deposition analysis using susceptibility weighted imaging and its association with body iron level in patients with mild cognitive impairment","volume":"16","author":"Gao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.peptides.2019.170169_bib0285","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.neurobiolaging.2013.10.078","article-title":"Genetic and biochemical markers in patients with Alzheimer\u2019s disease support a concerted systemic iron homeostasis dysregulation","volume":"35","author":"Crespo","year":"2014","journal-title":"Neurobiol. Aging"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119301470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119301470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:40:12Z","timestamp":1777527612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978119301470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":57,"alternative-id":["S0196978119301470"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170169","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic hepcidin quantified with LC\u2013MS\/MS in dementia in association with disease pathology and severity and with structural changes in the brain","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2019.170169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170169"}}